PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 32 filers reported holding PROQR THRAPEUTICS N V in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $10,000 | 0.0% | 1,900 | 0.0% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 1,900 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | +200.0% | 1,900 | +375.0% | 0.00% | – |
| Q3 2016 | $3,000 | -57.1% | 400 | -73.3% | 0.00% | – |
| Q2 2016 | $7,000 | +250.0% | 1,500 | +275.0% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |